Table 3

Procedural details of 690 patients undergoing TAVI stratified according to the occurrence of at least moderate post-procedural AR

AR≥2/4 (n=119)AR<2/4 (n=571)p ValueOR (95% CI)
Operative TAVI5 (4.2)25 (4.4)0.930.96 (0.36 to 2.56)
 Transapical5 (4.2)19 (3.3)0.641.27 (0.47 to 3.48)
 Transaortic06 (1.1)0.26
Percutaneous TAVI114 (95.8)546 (95.6)0.931.04 (0.39 to 2.78)
 Transfemoral111 (93.3)527 (92.3)0.711.16 (0.53 to 2.53)
 Transaxillary3 (2.5)19 (3.3)0.650.75 (0.22 to 2.58)
Valve type
 CoreValve104 (87)478 (84)0.311.35 (0.75 to 2.42)
 Edwards15 (13)93 (16)0.330.75 (0.42 to 1.35)
Procedural duration (min)92.9±49.684.7±46.30.08
Fluoroscopy time (min)15.5±7.114.9±6.80.39
Contrast amount (ml)174.7±70.4168.4±68.60.44
Post-procedural mean transvalvular PG (mm Hg)3.6±5.25.9±6.2<0.0001
Post-procedural AR119 (100)380 (66.5)<0.0001
 None0191 (33.5)
 Grade I0380 (66.5)
 Grade II103 (86.6)0
 Grade III14 (11.8)0
 Grade IV2 (1.7)0
  • Values are n (%) or mean±SD.

  • AR, aortic regurgitation; PG, pressure gradient; TAVI, transcatheter aortic valve implantation.